Novel Cell Therapy Using Mesenchymal Stromal Cell Sheets for Medication-Related Osteonecrosis of the Jaw

Novel Cell Therapy Using Mesenchymal Stromal Cell Sheets for Medication-Related Osteonecrosis of the Jaw

Despite medication-related osteonecrosis of the jaw (MRONJ) being first reported in 2003, the optimal treatment and prevention modalities for MRONJ are not clear. As a result, dentistry, oral surgery, and departments involved in the treatment of cancer and bone diseases are struggling with the manag...

Full description

Bibliographic Details
Main Authors:	Nobuyuki Kaibuchi, Takanori Iwata, Yoko Kawase Koga, Toshihiro Okamoto
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-05-01
Series:	Frontiers in Bioengineering and Biotechnology
Subjects:	multipotent stromal cells cell sheet medication related osteonecrosis of the jaw antiresorptive agent-related osteonecrosis of the jaw periodontal ligament cell therapy
Online Access:	https://www.frontiersin.org/articles/10.3389/fbioe.2022.902349/full

Similar Items

Medication-Related Osteonecrosis of the Jaw: A Critical Narrative Review
by: Alejandro I. Lorenzo-Pouso, et al.
Published: (2021-09-01)

Medication-Related Osteonecrosis of the Jaw in Dental Practice: A Retrospective Analysis of Data from the Milan Cohort
by: Cristina Mirelli, et al.
Published: (2022-05-01)

Clinical profile of individuals with bisphosphonate-related osteonecrosis of the jaw: an integrative review
by: Aloizio Premoli Maciel, et al.
Published: (2020-07-01)

Immune Dysfunction in Medication-Related Osteonecrosis of the Jaw
by: Ilaria Roato, et al.
Published: (2023-04-01)

Medication-related osteonecrosis of the jaw: Prosthodontic considerations
by: Islam E. Ali, et al.
Published: (2022-11-01)

What Do Prescribers of Bone Modifying Agents Know about Medication-Related Osteonecrosis of the Jaw? Is Current Prevention Enough?
by: Mihai Vlad Golu, et al.
Published: (2022-09-01)

Incidence of antiresorptive agent-related osteonecrosis of the jaw: A multicenter retrospective epidemiological study in Hyogo Prefecture, Japan
by: Masanori Nashi, et al.
Published: (2023-07-01)

<i>ONJ (MRONJ) Update 2021</i>—Osteonecrosis of Jaw Related to Bisphosphonates and Other Drugs—Prevention, Diagnosis, Pharmacovigilance, Treatment: A 2021 Web Event
by: Vittorio Fusco, et al.
Published: (2022-04-01)

Osteonecrosis of the jaws in patients under osteoporosis treatment: a nine-year experience report
by: Daniela Cia Penoni, et al.
Published: (2023-05-01)

Epi-Mucosa Fixation and Autologous Platelet-Rich Fibrin Treatment in Medication-Related Osteonecrosis of the Jaw
by: Antonio Cortese, et al.
Published: (2021-04-01)

Medication-Related Osteonecrosis of the Jaw: A Cross-Sectional Survey among Urologists in Switzerland, Germany, and Austria
by: Salvatore Calderaro, et al.
Published: (2023-01-01)

Bisphosphonate-Related Osteonecrosis of the Jaws. A Severe Side Effect of Bisphosphonate Therapy
by: Zuzana Janovská
Published: (2012-01-01)

Medication-Related Osteonecrosis: Why the Jawbone?
by: Sydney Kuehn, et al.
Published: (2023-04-01)

Surgical management in patients with bisphosphonate-related osteonecrosis of the jaw: four cases
by: Emre Dikicier, et al.
Published: (2014-12-01)

Therapeutic Effect of Benidipine on Medication-Related Osteonecrosis of the Jaw
by: Ken Matsunaka, et al.
Published: (2022-08-01)

Genome-wide association study of osteonecrosis of the jaw in Danish patients receiving antiresorptive therapy for osteoporosis: A case-control study
by: Alma B. Pedersen, et al.
Published: (2023-06-01)

Identification of Potentially Pathogenic Variants Associated with Recurrence in Medication-Related Osteonecrosis of the Jaw (MRONJ) Patients Using Whole-Exome Sequencing
by: Songmi Kim, et al.
Published: (2022-04-01)

Intraosseous Squamous Cell Carcinoma Associated with Denosumab-Induced Osteonecrosis of the Jaw
by: Sandra Bacián Martínez, et al.
Published: (2021-08-01)

BISPHOSPHONATES RELATED OSTEONECROSIS OF THE JAW IN CANCER PATIENTS – EPIDEMIOLOGICAL STUDY
by: George Adrian Ciobanu, et al.
Published: (2022-08-01)

Does Medication-Related Osteonecrosis of the Jaw Influence the Quality of Life of Cancer Patients?
by: Gianluca Tenore, et al.
Published: (2020-04-01)

Sclerotic bone: a sign of bone reaction in patients with medication related osteonecrosis of the jaw
by: Katharina Theresa Obermeier, et al.
Published: (2024-04-01)

Spontaneous medication-related osteonecrosis of the jaws in a 23-year-Old
by: Brenden J. Manley, et al.
Published: (2023-03-01)

Autologous bone marrow stem cell intralesional transplantation repairing bisphosphonate related osteonecrosis of the jaw
by: Cella Luigi, et al.
Published: (2011-08-01)

Electron microscopic analysis of necrotic bone and failed implant surface in a patient with medication-related osteonecrosis of the jaw
by: Ji Young Ha, et al.
Published: (2023-10-01)

Review of the effect of biphosphonates on jaw osteonecrosis
by: Afshin Tahmasebi, et al.
Published: (2011-01-01)

Bisphosphonate-related osteonecrosis of the jaw: specificities
by: Siri Paulo, et al.
Published: (2014-09-01)

Bisphosphonates and Their Connection to Dental Procedures: Exploring Bisphosphonate-Related Osteonecrosis of the Jaws
by: Emily Sunny Lee, et al.
Published: (2023-11-01)

A clinical retrospective study of implant as a risk factor for medication-related osteonecrosis of the jaw: surgery vs loading?
by: Yong-Dae Kwon, et al.
Published: (2023-09-01)

Medication-Related Osteonecrosis of the Jaws (MRONJ) in Children and Young Patients—A Systematic Review
by: Hemil Dario Rosales, et al.
Published: (2023-02-01)

Development of Osteonecrosis of the Jaw in a Patient Receiving Oral Bisphosphonates for Osteoporosis: A Case Report
by: Sina Esmaeilzadeh, et al.
Published: (2014-08-01)

Infection as an Important Factor in Medication-Related Osteonecrosis of the Jaw (MRONJ)
by: Sven Otto, et al.
Published: (2021-05-01)

The Use of Human Amniotic Membrane (hAM) as a Treatment Strategy of Medication-Related Osteonecrosis of the Jaw (MRONJ): A Systematic Review and Meta-Analysis of the Literature
by: Roberto Sacco, et al.
Published: (2023-05-01)

18 Years of Medication-Related Osteonecrosis of the Jaw (MRONJ) Research: Where Are We Now?—An Umbrella Review
by: Roberto Sacco, et al.
Published: (2021-09-01)

Medication-Related Osteonecrosis of the Jaws Initiated by Zoledronic Acid and Potential Pathophysiology
by: Aya Alsalih, et al.
Published: (2021-07-01)

Medication‐related osteonecrosis of the jaw leading to sepsis in a patient with rheumatoid arthritis: A case report and clinical implications
by: Kazuhiko Iwasaki, et al.
Published: (2023-06-01)

OSTEONECROSIS OF THE JAW ASSOCIATED WITH SHORT-COURSE AND LOW-DOSE CORTICOSTEROID THERAPY
by: Lavinia Cristina Pădurariu, et al.
Published: (2023-12-01)

Romosozumab-associated medication-related osteonecrosis of the jaw
by: Benjamin Palla, et al.
Published: (2023-06-01)

Can medication-related osteonecrosis of the jaw be attributed to specific microorganisms through oral microbiota analyses? A preliminary study
by: Heon-Young Kim, et al.
Published: (2024-02-01)

Resective Surgery versus Debridement in Stage 2 Medication-Related Osteonecrosis of the Jaw
by: Salvatore D’Amato, et al.
Published: (2021-09-01)

Spontaneous bisphosphonate-related osteonecrosis of the left hemi-mandible: Similarities with phossy jaw
by: Giuseppina Campisi, et al.
Published: (2012-01-01)